Summary
HF6 Chart
Frontline WSIB Workers Rally at Ford's Office Amid Growing Strike Tensions
TORONTO--(BUSINESS WIRE)-- #FordNation--Harry Goslin, President of the Ontario Compensation Employees Union (OCEU/CUPE 1750), will join striking Workplace Safety and Insurance Board (WSIB) workers on the picket line outside Premier Doug Ford's constituency office at 823 Albion Road in Etobicoke on Thursday, July 3, between 10:00 a.m. and 2:00 p.m. ET. This picket follows new revelations that WSIB has begun outsourcing core work performed by frontline union members, despite an ongoing province-wide strike now.
Frontline May Have Calmer Seas Ahead Of It
Frontline (FRO) remains a volatile but attractive long-term play, especially for investors able to stomach wild price swings and inconsistent dividends. Recent geopolitical improvements, especially the Iran-Israel ceasefire, should reduce shipping risks and costs, benefiting Frontline's operations and margins going forward. Despite a recent dividend cut and oil price risks, Frontline's high yield and potential for increased oil transport support a bullish long-term outlook.
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML
85% remission rate observed in evaluable frontline AML patients Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient No dose-limiting toxicities observed among evaluable patients; safety profile remains strong Evidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicity Mipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics ("Aptevo") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel bispecific immuno-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced new clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig, its first-in-class CD123 x CD3 bispecific antibody, in combination with standard-of-care venetoclax and azacitidine (ven/aza) for newly diagnosed patients with acute myeloid leukemia (AML) who are unfit for intensive chemotherapy. Across two trials, the mipletamig triplet therapy delivered remissions in 85% of evaluable frontline AML patients-which significantly exceeds results from competitor studies, including those achieved in the Viale A trial that evaluatedvenetoclax and azacitidine (ven/aza) as doublet therapy.
Frontline Plc Dividends
 FRO In 2 months Estimated | Quarterly | $0.18 Per Share |
| FRO 3 weeks ago Paid | Quarterly | $0.18 Per Share |
| FRO 3 months ago Paid | Quarterly | $0.2 Per Share |
| FRO 6 months ago Paid | Quarterly | $0.34 Per Share |
| FRO 9 months ago Paid | Quarterly | $0.62 Per Share |
| FRO 14 Jun 2024 Paid | Quarterly | $0.62 Per Share |
Frontline Plc Earnings
| 29 Aug 2025 (In 1 month) Date | | 0.48 Cons. EPS | - EPS |
| 23 May 2025 Date | | 0.19 Cons. EPS | 0.18 EPS |
| 28 Feb 2025 Date | | 0.2 Cons. EPS | 0.2 EPS |
| 29 Nov 2024 Date | | 0.44 Cons. EPS | 0.34 EPS |
| 30 Aug 2024 Date | | 0.67 Cons. EPS | 0.62 EPS |
| FRO In 2 months Estimated | Quarterly | $0.18 Per Share |
| FRO 3 weeks ago Paid | Quarterly | $0.18 Per Share |
| FRO 3 months ago Paid | Quarterly | $0.2 Per Share |
| FRO 6 months ago Paid | Quarterly | $0.34 Per Share |
| FRO 9 months ago Paid | Quarterly | $0.62 Per Share |
| FRO 14 Jun 2024 Paid | Quarterly | $0.62 Per Share |
| 29 Aug 2025 (In 1 month) Date | | 0.48 Cons. EPS | - EPS |
| 23 May 2025 Date | | 0.19 Cons. EPS | 0.18 EPS |
| 28 Feb 2025 Date | | 0.2 Cons. EPS | 0.2 EPS |
| 29 Nov 2024 Date | | 0.44 Cons. EPS | 0.34 EPS |
| 30 Aug 2024 Date | | 0.67 Cons. EPS | 0.62 EPS |
Frontline Plc (HF6) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Frontline Plc ever had a stock split?
Frontline Plc Profile
| Oil & Gas Midstream Industry | Energy Sector | Lars H. Barstad CEO | XSTU Exchange | CY0200352116 ISIN |
| BM Country | 85 Employees | 12 Jun 2025 Last Dividend | 3 Feb 2016 Last Split | 6 Aug 2001 IPO Date |
Overview
Frontline plc is a prominent shipping company with a focus on the seaborne transportation of crude oil and oil products across the globe. Established in 1985, the company is headquartered in Limassol, Cyprus, and has carved a niche for itself in the maritime transport industry over the years. As of the end of 2022, Frontline boasts a robust operational fleet of 70 vessels, showcasing its significant capacity to meet the demanding needs of global oil transportation. The company's business operations are not limited to transportation alone but also encompass the charter, purchase, and sale of vessels, highlighting its versatility and comprehensive involvement in the maritime sector.
Products and Services
- Seaborne Transportation of Crude Oil and Oil Products
Frontline plc specializes in the transportation of crude oil and various oil products across international waters. Utilizing its vast fleet of oil and product tankers, the company ensures efficient and reliable delivery of oil commodities to different parts of the world, adhering to the highest safety and environmental standards.
- Ownership and Operation of Oil and Product Tankers
The company owns and operates a diverse fleet of oil and product tankers, designed to meet the specific requirements of carrying crude oil and oil products. This capability enables Frontline plc to offer flexible and adaptive transportation solutions, catering to the unique needs of its clientele in the ever-evolving global oil market.
- Charter, Purchase, and Sale of Vessels
In addition to its core transportation services, Frontline plc engages in the chartering, purchasing, and selling of vessels. This aspect of its operations allows for strategic fleet management and the optimization of its assets to align with market demands and opportunities, thereby enhancing the company's growth and profitability potentials.
Contact Information
